MoneyWorks4Me

Biocon informs about disclosure

29 Feb 2024 Evaluate
Biocon has informed that it enclosed Company statement regarding ‘The U.S. Food and Drug Administration (FDA) conducted an inspection at Biocon Biologics Limited’s Biocon Campus (Site 1) facility between February 20-28, 2024.’ More details enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1791.95
Dr. Reddys Labs. 1200.55
Cipla 1323.45
Lupin 2001.10
Zydus Lifesciences 1135.00
View more..